Skip to main content

Dr. Moheb N. Boktor

Gastroenterology (Gastroenterology Physician)

  • Medicare participating

At a glance

Years since graduation
25
In the NPI registry since
2007
Medicare patients seen, 2024
226

Licensed in Texas since 2018, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Gastroenterology Physician primary
    TX license R9190 (first issued 2018; active) · LA license MD.203838
  • Internal Medicine Physician
    LA license MD.203838

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Gastroenterology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
226
Services billed
366
Patients’ average age
72
Most frequent Medicare services, 2023
ServiceTimesPatients
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes4645
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope4646
Biopsy of large bowel using a flexible endoscope4040
Established patient office or other outpatient visit, 30-39 minutes3433
Removal of polyps or growths of large bowel using an endoscope with mechanical snare2828
Established patient office or other outpatient visit, 40-54 minutes1616
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope1312

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Ondansetron Hcl
Other prescribers in Dallas, TX
71
Gavilyte-G (peg3350/sod sulf,bicarb,cl/kcl)
Other prescribers in Dallas, TX
60
Sod Sulf-Potass Sulf-Mag Sulf (sodium, potassium,mag sulfates)
Other prescribers in Dallas, TX
60
Stelara (ustekinumab)32
Peg-3350 And Electrolytes (peg3350/sod sulf,bicarb,cl/kcl)
Other prescribers in Dallas, TX
26
Omeprazole
Other prescribers in Dallas, TX
13
Lubiprostone
Other prescribers in Dallas, TX
11

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 5 companies reported 17 payments worth $1,059 in total to this clinician.

By company
Janssen Biotech, Inc.$363
AbbVie Inc.$344
Janssen Scientific Affairs, LLC$306
Lilly USA, LLC$26.48
Dynavax Technologies Corporation$19.95
By type
Food and Beverage$960
Education$99.00

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Sep 3, 2025Janssen Biotech, Inc.
Sep 3, 2025
Education
TREMFYA · Immunology · in-kind
$99.00

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Texas →

Industry-funded research

Named as a principal investigator on 7 industry-funded studies in 2025, from 4 companies. The companies reported $587,527 in research payments for these studies, mostly to the institutions running them.

  • A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis (DUET-UC)
    Janssen Research & Development, LLC
  • A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.
    AbbVie Inc. · Active, not recruiting · NCT06063967
  • A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease (DUET-CD)
    Janssen Research & Development, LLC
  • A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn s Disease
    AbbVie Inc.
  • UC P3: Double-Blind Treat Straight Through
    F. Hoffmann-la Roche AG
  • CD P3: Double-Blind Induction
    F. Hoffmann-la Roche AG
  • UC P3: Double-Blind Treat Straight Through
    Genentech, Inc.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Gastroenterology clinicians in Dallas

Sources

NPI registry (CMS NPPES, November 2026; record last updated January 8, 2019), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1811187354. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.